Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

685 results about "Clostridiales" patented technology

An order of anaerobic bacteria that are predominantly GRAM POSITIVE within the phylum Firmicutes. It includes the Clostridium and Eubacterium genera.

Clostridium butyricum and application thereof

The invention discloses clostridium butyricum and application thereof, and belongs to the technical field of microorganisms. The clostridium butyricum is preserved in the China Center for Type Culture Collection on September 7, 2023, and the preservation number is CCTCC NO: M 20231636. The clostridium butyricum JBH-KOLONIZER BD-10 or a fermentation product provided by the invention not only has the common advantages of a clostridium butyricum microecological preparation, but also can be used as a laying hen feed additive, so that the feed intake of laying hens can be obviously reduced, and the production cost can be reduced. The quality of the eggs is not influenced while the grains are saved, and the breeding benefit is increased.
Owner:HENAN JINBAIHE BIOTECH CO LTD +1

Probiotic microcapsule with function of improving intestinal microecology and key technology

The invention relates to the technical field of biological pharmacy, and discloses a probiotic microcapsule with a function of improving intestinal microecology, which comprises the following components in percentage by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU of lactobacillus rhamnosus; lactobacillus acidophilus: each gram of the formula contains 109 CFU; clostridium butyricum: each gram of the formula contains 108 CFU; 5%-8% of a nano sodium alginate-chitosan compound; 3%-5% of peptide nanoparticles; 2%-4% of a natural polymer intelligent response film; 3%-6% of arabinoxylan oligosaccharide; 4%-7% of resistant dextran; 2%-4% of lentinan; and 0.1%-0.3% of resveratrol. Through a double-layer or three-layer embedding technology of the nano sodium alginate-chitosan compound and the intelligent response polymer film, the tolerance of the probiotics in gastric acid and cholate environments is remarkably enhanced, and targeted release of the probiotics in small intestines and colon is ensured.
Owner:HENAN BUSINESS SCI RES INST

Probiotic-polyphenol nanoparticle colon-targeted co-delivery system as well as preparation method and application thereof

The invention discloses a probiotic-polyphenol nanoparticle colon-targeted co-delivery system as well as a preparation method and application thereof, and belongs to the field of biological medicines. The FCPs and hyaluronic acid (HA) are combined through non-covalent interaction, so that the hydrogel has colon targeting property and mucosal adhesion at the same time, and delivery of probiotics is facilitated. The hydrogel (HF) based on polysaccharide has good biocompatibility, and can be used for effectively encapsulating the probiotics and the natural products. Then, the PDA-TH NPs and BA are incorporated into the polysaccharide chain network of HF, and finally the BA-HF-PDAT targeted co-delivery system is constructed. The BA (at) HF-PDAT targeted co-delivery system can protect BA from serious gastrointestinal stress, and is jointly assembled with PDT-TH NPs to realize dual slow release of thymol (Thy), so that the treatment effect of BA and Thy is improved, and the BA (at) HF-PDAT targeted co-delivery system contributes to treatment of clostridium difficile infection (CDI).
Owner:NORTHWEST A & F UNIV

High-efficiency denitrification method and system for landfill leachate

The invention discloses an efficient denitrification method and system for landfill leachate, and the method comprises the following steps: diluting waste molasses, and then adding a compound enzyme preparation containing cellulase, pectinase and alpha-amylase for enzymolysis pretreatment to obtain a pretreatment solution; inoculating the pretreatment liquid with a compound flora containing clostridium butyricum and succinic acid-producing anaerobic spirillum, carrying out anaerobic fermentation, and separating to obtain a liquid carbon source containing acetic acid and propionic acid and fermentation residues; mixing the fermentation residues with waste sugar residues, and performing pyrolysis to prepare biochar; and synchronously adding the liquid carbon source and the biochar into a denitrification reactor, and carrying out denitrification on the landfill leachate. The total nitrogen removal load of the landfill leachate denitrification system is increased by 60% compared with that of a single carbon source process, and the sugar manufacturing solid waste recycling rate gt is achieved; 95%. According to the method disclosed by the invention, the dual goals of efficient denitrification and solid waste recycling are achieved through cooperative treatment of the waste molasses and the waste sugar residues in the sugar manufacturing process.
Owner:HUNAN DEEYA ENVIRONMENTAL ENG CO LTD

Fermentation medium for regulating and controlling target product of clostridium aerovorans and fermentation method of fermentation medium

The invention discloses a fermentation medium for regulating and controlling a clostridium aerovorans target product and a fermentation method of the clostridium aerovorans target product. The medium comprises a basic component and a regulating component, the basic components comprise ammonium chloride, potassium chloride, magnesium sulfate heptahydrate, sodium chloride, monopotassium phosphate, yeast powder, calcium chloride dihydrate, sodium selenite, nickel chloride hexahydrate, biotin, folic acid, pyridoxine hydrochloride, thiamine, riboflavin, nicotinic acid, D-calcium pantothenate, cobalamin, para aminobenzoic acid and lipoic acid; the adjusting component comprises sodium tungstate, ferrous sulfate and sodium molybdate, sodium tungstate and ferrous sulfate have a forward adjusting effect on increasing the yield of acetic acid, ethanol and butanol in the target product, and sodium molybdate has a reverse adjusting effect on the target product. By optimizing the proportion of trace elements in the culture medium, the clostridium metabolism efficiency is improved, synthesis of a target product is regulated and controlled, and the method is particularly suitable for industrial production of acetic acid, ethanol, butanol and the like.
Owner:NANJING SHIQI BIOCHEMICAL TECH CO LTD

Method for producing hydrogen by degrading non-detoxified biomass and application of method

The invention relates to the technical field of biomass hydrogen production, and particularly discloses a method for producing hydrogen by degrading non-detoxified biomass and application of the method. Comprising the following operation steps: step 1, preparing a seed expanding culture solution, namely respectively inoculating a seed culture medium I and a seed culture medium II with anaerobacter thermosaccharolyticus and clostridium thermocellum, activating and performing expanding culture; respectively obtaining a seed expanding culture solution I and a seed expanding culture solution II; step 2, preparation of a fermentation culture medium: (1) putting waste biomass into a pretreatment solution for pretreatment, and carrying out solid-liquid separation to obtain pretreated biomass; (2) preparing a fermentation culture medium by taking the pretreated biomass as a carbon source; 3, under inert gas, after sterilization, the seed propagation liquid I and the seed propagation liquid II are inoculated into a fermentation medium according to a certain proportion, dark fermentation is conducted for 16-32 h at the temperature of 50-60 DEG C and the rotating speed of 100-200 rpm, and hydrogen is obtained.
Owner:DONGGUAN UNIV OF TECH

Clostridium cadaverum strain and application thereof

The invention discloses a clostridium corpse strain and application thereof. The preservation number of the clostridium cadaveris J038 strain of the clostridium cadaveris J038 strain is CGMCC (China General Microbiological Culture Collection Center) NO. 35440, and the clostridium cadaveris J038 strain of the clostridium The clostridium corpse J038 strain is separated from pig manure for the first time, and 4-hydroxyphenylpropionic acid is produced by metabolism of the clostridium corpse J038 strain. In addition, the invention further provides application of the clostridium corpse in preparation of 4-hydroxyphenylpropionic acid, and when the clostridium corpse is adopted to prepare 4-hydroxyphenylpropionic acid, the clostridium corpse has the advantages of being small in environmental pollution, high in sustainability, precise, green, efficient and the like; the yield is high, and the increasing requirements of the fields of medicine, food, agriculture and the like on the 4-hydroxyphenylpropionic acid can be met.
Owner:MAIYUAN LABORATORY

Application of indolepropionic acid in treatment of clostridium difficile infection

The invention discloses application of indolepropionic acid in treatment of clostridium difficile infection, and relates to the technical field of medicines. The invention discloses application of indolepropionic acid in preparation of a medicine for treating clostridium difficile infectious diseases and complications thereof. Compared with other types of AhR agonists, such as indole-3-formaldehyde, 3-indolecarbinol, indole-3-pyruvic acid and indolepropionic acid, have better effects in treatment of clostridium difficile infection, and can more effectively reduce the cytotoxicity of clostridium difficile strains.
Owner:SHENZHEN HOSPITAL OF SOUTHERN MEDICAL UNIV

Microecological preparation with immunological enhancement function and application of microecological preparation in antibiotic-free breeding of livestock and poultry

The invention provides a microecological preparation with an immunological enhancement function and application of the microecological preparation in antibiotic-free breeding of livestock and poultry, and relates to the technical field of agricultural biology. The microecological preparation with the immunological enhancement function comprises a probiotic component, a prebiotics component and an immunological enhancement component, and the probiotic component, the prebiotics component and the immunological enhancement component are respectively composed of lactic acid bacteria, bacillus, clostridium butyricum, fructo-oligosaccharide, yeast beta-glucan, astragalus polysaccharide and chitosan oligosaccharide. Wherein the lactic acid bacteria accounts for 30%-40%, the bacillus accounts for 20%-30%, the clostridium butyricum accounts for 10%-20%, the fructo-oligosaccharide accounts for 5%-10%, the yeast beta-glucan accounts for 3%-8%, the astragalus polysaccharide accounts for 2%-5%, and the chitosan The probiotics can enhance immunity and regulate intestinal tracts at the same time, the effect is improved by 40% or above compared with common probiotics, animals suffer less illness and grow fast, flora can resist high temperature and gastric acid through a special protection technology, the loss of viable bacteria is less than 5% after the probiotics are stored for 3 months, and the probiotics are stable by two times compared with conventional products.
Owner:杨美兰

Gene influencing performance of clostridium in synthesizing ethanol by using carbon gas and application of gene

PendingCN120718932ABacteriaBiofuelsBiotechnologyEthanol synthesis
The invention discloses an application of some functional genes in improving the performance of clostridium for synthesizing ethanol by utilizing one-carbon gas fermentation, wherein overexpression genes NCBI (National Center for Biotechnology Information) are CLJUc04490, CLJUc25060, CLJUc06990, CLJUc22650 and / or CLJUc07720, and expression of inhibition genes CLJUc09160 and / or CLJUc23840 can be used for improving the autotrophic growth capability and the ethanol synthesis yield of clostridium Yangdall when the clostridium Yangdall is fermented by utilizing C1 gas; therefore, the economical efficiency of the clostridium yangdall fermentation is improved.
Owner:CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI

Subunit vaccine for resisting clostridium perfringens of poultry

The invention provides a subunit vaccine for resisting poultry clostridium perfringens, which is characterized in that CPA and NetB proteins are truncated, and three gene sequences of auxiliary protease Fba are connected in series and fused through Linker to obtain recombinant protein. Immunogenicity detection on the N-C-F recombinant protein finds that the N-C-F recombinant protein can induce SPF chicken to generate antibodies. Immune protection test results show that the subunit vaccine prepared from the N-C-F protein and the adjuvant can achieve 100% immune protection effect when being used for immunizing 100 [mu] g / chicken and 200 [mu] g / chicken, and the subunit vaccine can be used as a subunit vaccine for resisting various toxin types.
Owner:CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENT

Composition, feed and use for reducing odorous substances in poultry

The present invention belongs to the field of biotechnology, and discloses a composition for reducing the emission of odorous substances from poultry, comprising rutin or mulberry leaf extract, Clostridium butyricum, and Bacillus subtilis; the mass ratio of rutin or mulberry leaf extract, Clostridium butyricum, and Bacillus subtilis is 1-3:0.5-1.5:1; the specification of Clostridium butyricum is 1 billion CFU / g, and the specification of Bacillus subtilis is 1 billion CFU / g. The composition utilizes the flavonoid additive rutin or mulberry leaf extract, Bacillus subtilis, and Clostridium butyricum in combination, which can significantly improve the ability of Bacillus subtilis and Clostridium butyricum to inhibit odor. At the same time, the present invention also discloses the application and feed of the composition.
Owner:ANIMAL SCI RES INST GUANGDONG ACADEMY OF AGRI SCI

Clostridium butyricum as well as culture method and application thereof

The invention discloses clostridium butyricum as well as a culture method and application thereof, belongs to the field of feed additives, and aims to solve the problems that a controllable fattening period is shortened and the efficacy of the clostridium butyricum cannot be completely exerted due to the fact that a wide range of clostridium butyricum needs a relatively long adaptation period for an endogenous intestinal environment of an animal. The clostridium butyricum from the North Naa Biotechnology Co., Ltd. Is cultured by simulating an animal endogenous environment in vitro, and after the clostridium butyricum which completely adapts to animal endogenous is obtained, the screened animal endogenous clostridium butyricum is coated by adopting a coating technology, so that the clostridium butyricum is not damaged by a strong acid environment in an animal stomach bag; the clostridium butyricum strain has the advantages that the clostridium butyricum strain can be used for preparing animal endogenous clostridium butyricum, a large quantity of animal endogenous clostridium butyricum can reach intestinal tracts and be released, and the animal endogenous clostridium butyricum can quickly adapt to animal intestinal environment due to higher adaptability of the strains, and can quickly form efficient colonization and functional expression under the condition of almost no adaptation period. The feed additive can be used as a biological feed additive.
Owner:DINGZHENG XINXING BIOTECH TIANJIN

Application of probiotic composition in preparation of medicine for preventing and treating ulcerative colitis

The invention belongs to the field of microorganisms. The invention provides an application of a probiotic composition in preparation of medicines for preventing and treating ulcerative colitis, the probiotic composition comprises a combination of bacillus coagulans and clostridium butyricum, and the combination of bacillus coagulans and clostridium butyricum comprises a combination of bacillus coagulans and clostridium butyricum. The bacillus coagulans is bacillus coagulans JSSW-LA-07-1 with the preservation number of CGMCC (China General Microbiological Culture Collection Center) No.10182, and the clostridium butyricum is clostridium butyricum JSIM-MCB20040312 with the preservation number of CGMCC No.1647. The bacillus coagulans and the clostridium butyricum are used for preparing the bacillus coagulans and the clostridium butyricum. The probiotic composition has the capacity of preventing and treating ulcerative colitis, the ulcerative colitis treating effect is better than that of positive control medicine salazosulfapyridine, the obvious ulcerative colitis treating effect is achieved, the inflammatory factor content and the oxidative stress level are remarkably reduced, inflammatory cell infiltration is reduced, intestinal flora imbalance is improved, and the effect of preventing and treating ulcerative colitis is achieved. Meanwhile, the effect of promoting planting of probiotics is achieved.
Owner:SHANGHAI FOURTH PEOPLES HOSPITAL

Method for promoting acid production and alcohol production through fermentation of clostridium perdali C1 gas by using biogenic carbon-based redox regulation and control medium

The invention discloses a method for promoting acid production and alcohol production through fermentation of clostridium perdali C1 gas by using a biological source carbon-based redox regulation and control medium. The preparation method comprises the following steps: obtaining biochar by adopting a high-temperature pyrolysis method, grinding and sieving to obtain a biogenic carbon-based redox regulation medium, adding the biogenic carbon-based redox regulation medium into a fermentation culture medium, inoculating clostridium perdali into a fermentation device filled with the fermentation culture medium, controlling the volume ratio of H2 to CO2 in the fermentation device to be (1.5: 1)-(2.5: 1), and carrying out anaerobic fermentation for 20-30 days to obtain the biogenic carbon-based redox regulation medium. According to the invention, a biological source carbon-based redox regulation medium is introduced into a clostridium perdali gas fermentation system, and the medium not only can enrich CO2 gas, but also can improve the mass transfer efficiency of a gaseous substrate; the method has the advantages that the method is simple and convenient to operate, extra reducing power is provided for a fermentation system, electron transfer is mediated, the CO2 utilization rate of the strain and the fermentation product generation rate are remarkably increased, secondary resource utilization of solid waste biomass is achieved, C1 gas is effectively converted into high-value chemicals, and a green, economical and sustainable development road is provided for conversion of CO2.
Owner:DALIAN UNIV OF TECH +1

Clostridium butyricum as well as composition and application thereof

The invention relates to the technical field of microorganisms, and provides Witzia ciliaris KY009 (preservation number is CGMCC (China General Microbiological Culture Collection Center) NO. 33480) and Clostridium butyricum KY002 (preservation number is CGMCC NO. 33478), and the two strains are separated from an excrement sample. Experiments prove that the two strains can obviously improve the sperm quality and quantity, regulate the sex hormone level, improve the intestinal inflammation symptom and regulate the expression of related inflammatory factors. The invention also provides a composition containing the two strains, wherein the composition comprises a food composition, a pharmaceutical composition, a health-care product composition, a functional microbial agent and the like. The compositions are useful for improving reproductive health, modulating sex hormone levels, treating intestinal inflammation and promoting mucosal repair, and alleviating metabolic and immune related diseases. The strain and the composition provided by the invention have wide application prospects in the fields of medicines, foods and health-care products.
Owner:SHANGHAI LISHAN BIOPHARMACEUTICAL CO LTD +1

Clostridium difficile triple detection kit based on colloidal gold immunochromatography and preparation method of clostridium difficile triple detection kit

The invention relates to a clostridium difficile triple detection kit based on colloidal gold immunochromatography and a preparation method of the clostridium difficile triple detection kit, and belongs to the technical field of immunodetection. The clostridium difficile triple detection kit provided by the invention comprises a clostridium difficile triple detection card and a sample diluent, and the clostridium difficile triple detection card is formed by arranging and connecting three detection test strips in parallel; the detection test strip comprises a clostridium difficile toxin A detection test strip, a clostridium difficile toxin B detection test strip and a clostridium difficile glutamate dehydrogenase detection test strip. By using the clostridium difficile triple detection kit provided by the invention, three markers related to clostridium difficile can be detected at the same time, the detection limit of clostridium difficile toxin A is 0.25 ng / mL, the detection limit of clostridium difficile toxin B is 0.5 ng / mL, and the detection limit of clostridium difficile glutamate dehydrogenase is 0.5 ng / mL, so that the clostridium difficile triple detection kit has the advantages of good sensitivity, simplicity in operation, high sensitivity, high sensitivity, high sensitivity and the like. The method is suitable for large-scale popularization screening.
Owner:SHAOXING BEYOND MEDICAL TECH CO LTD

Culture medium for regulating acetyl coenzyme A derivative and use method thereof

PendingCN119193394ABacteriaBiofuelsBiotechnologyClostridium autoethanogenum
The invention relates to the technical field of synthesis gas fermentation, in particular to a culture medium for regulating an acetyl coenzyme A derivative and a use method of the culture medium. The culture medium is used for regulating and controlling the yield of ethanol and the yield of acetic acid generated by an acetyl coenzyme A derivative in the ethanol-producing clostridium; the culture medium comprises ferrous sulfate, the weight content of the ferrous sulfate is in negative correlation with the yield of ethanol, and the weight content of the ferrous sulfate is in positive correlation with the yield of acetic acid. According to the culture medium, along with the weight content change of the ferrous sulfate and the content change of the ethanol and the acetic acid generated by the ethanol-producing clostridium, the yield of the ethanol and the acetic acid in a synthetic product of the ethanol-producing clostridium is adjusted by adjusting the content change of the ferrous sulfate; therefore, the controllability of the synthetic product of the clostridium ethanoliforme can be comprehensively improved.
Owner:BEIJING SHOUGANG LANZATECH TECH CO LTD +1

Bacillus subtilis with antibacterial function and application thereof

The invention provides bacillus subtilis with an antibacterial function and application of the bacillus subtilis. The preservation number of the bacillus subtilis is CGMCC (China General Microbiological Culture Collection Center) NO.31500. The bacillus subtilis JRB-K2 screened by the invention has a remarkable inhibition effect on various pathogenic bacteria such as escherichia coli, staphylococcus aureus, salmonella, clostridium perfringens and the like. The screened bacillus subtilis also has a high survival rate when the temperature is close to the feed granulation temperature. The screened strain can effectively inhibit intestinal inflammation caused by escherichia coli, salmonella, clostridium perfringens and other pathogenic bacteria, promote animal digestion, improve the feed utilization rate and improve the culture benefits, and has wide application prospects in the aspect of microbial feed additive research.
Owner:山东鸿琪生物科技有限公司

Bacillus amyloliquefaciens and application thereof in biological fermentation feed

The invention discloses bacillus amyloliquefaciens with the characteristic of inhibiting mould growth and application of the bacillus amyloliquefaciens, and belongs to the field of microorganisms and fermentation engineering, the bacillus amyloliquefaciens is preserved in China General Microbiological Culture Collection Center on August 5, 2024, and the preservation number is CGMCC No.31538. The strain is bacillus amyloliquefaciens obtained by screening, separating and purifying from peasant pickles, and the strain can inhibit the growth of escherichia coli, clostridium perfringens and mould. The bacillus amyloliquefaciens disclosed by the invention solves the problem of insufficient effect of a microorganism mildew-proof method of the existing fermented feed, and the bacillus amyloliquefaciens is added into the biological fermented feed, so that the quantity of harmful microorganisms in the biological fermented feed can be effectively reduced, the generation of mycotoxin is inhibited, the feed is prevented from mildewing and going bad, and the shelf life of the feed is prolonged.
Owner:TANGRENSHEN GRP CO LTD

Clostridium perfringens bacteriophage as well as composition, kit and application thereof

The invention relates to a clostridium perfringens phage and application thereof. The bacteriophage is a clostridium perfringens bacteriophage P2ACQJS03 (wherein the clostridium perfringens bacteriophage P2ACQJS03), and the preservation number of the clostridium perfringens bacteriophage P2ACQJS03 in the China Center for Type Culture Collection (CCTCC) is CCTCC NO: M 20242430. The bacteriophage provided by the invention is a virulent bacteriophage separated from the nature, tests prove that the bacteriophage has no toxic effect on normal microbial flora, and the DNA of the bacteriophage cannot encode virulence genes, so that the bacteriophage is high in stability; the bacteriophage disclosed by the invention is wide in host range, and large-scale industrial production can be realized. The bacteriophage provides an excellent strain resource for developing a novel antibacterial preparation, and has a good application and development prospect.
Owner:EMMEFEI (NANJING) BIOTECHNOLOGY CO LTD

Method for improving utilization of clostridium synthesis gas

The invention discloses a method for improving utilization of synthesis gas of clostridium. The method comprises the following steps: blocking or down-regulating expression of a transcription factor NrdR; and / or enhancing the expression of a transcription factor DeoR. The method provided by the invention effectively improves the utilization and conversion efficiency of the clostridium aerovorans on the carbon gas such as synthesis gas, and has popularization and application values.
Owner:CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI +1

Clostridium butyricum NCU-27 and application thereof

ActiveCN118956699APromote productionImprove postoperative IRBacteriaMetabolism disorderBiotechnologyShort-chain fatty acid metabolism
The invention belongs to the technical field of biological medicine, and particularly relates to clostridium butyricum NCU-27 and application thereof. The clostridium butyricum NCU-27 is preserved in China General Microbiological Culture Collection Center (CGMCC) on July 22, 2024, the address of the clostridium butyricum NCU-27 is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, and the preservation number of the clostridium butyricum NCU-27 is CGMCC NO.31386. The clostridium butyricum NCU-27 is named as clostridium butyricum NCU-27, and the clostridium butyricum NCU-27 is named as clostridium butyricum NCU-27. According to the data of the embodiment of the invention, the clostridium butyricum NCU-27 provided by the invention improves the postoperative IR of a gastrectomy SD (Sprague Dawley) rat model by regulating intestinal microbiota and short-chain fatty acid metabolism, especially increasing the production of butyric acid. The improvement effect can be realized through an enterohepatic axis and an mTORC1 signal channel, and a potential strategy is provided for clinically using probiotics and butyric acid derivatives to treat postoperative IR in the future.
Owner:NANCHANG UNIV

Application of clostridium butyricum in treating autism

According to the application of the clostridium butyricum in treatment of the autism, in a constructed maternal immune activated mouse autism model, the clostridium butyricum can mediate the intestinal barrier function and effectively improve the autism symptom by adjusting the balance of intestinal flora, increasing the permeability of the intestinal barrier function, inhibiting inflammatory factors and the like. The clostridium butyricum has the possibility of being used as the medicine for improving the autism, and a new application field is provided for the clostridium butyricum.
Owner:JIANGXI CHENGGE BIOTECHNOLOGY CO LTD

A method for preparing Clostridium perfringens epsilon toxin-ferritin nanoparticle antigen

ActiveCN118931931BBacterial antigen ingredientsAntibacterial agentsClostridium perfringens epsilon toxinClostridial toxin
The invention discloses a method for preparing a Clostridium perfringens epsilon toxin-ferritin nanoparticle antigen, comprising constructing a soluble E toxin mutant and a soluble Ferritin protein respectively and purifying them, and then self-assembling the soluble E toxin mutant and the soluble Ferritin protein to form a nanoparticle antigen. The epsilon-ferritin nanoparticles prepared by the invention significantly promote the production of IgG in antigen-immunized mice and successfully induce a cellular immune response.
Owner:INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Method and system for producing high-purity medium-chain fatty acid based on waste molasses two-stage regulation fermentation

The invention discloses a method and a system for producing high-purity medium-chain fatty acid (MCFA) based on waste molasses two-stage regulation fermentation. Comprising the following steps: (1) diluting waste molasses, then adding a compound enzyme agent of pectinase, beta-glucanase and cellulase, and coupling microwave to assist treatment; (2) inoculating the pretreated waste molasses with a composite flora containing a clostridium kluyveri mutant strain and a Megasphaera elsdeni engineering bacterium, and carrying out a fermentation treatment on the waste molasses, wherein the composite flora contains the clostridium kluyveri mutant strain and the Megasphaera elsdeni engineering bacterium; (3) sequentially performing two-stage dynamic regulation and control fermentation on the waste molasses inoculated with the composite flora through a pH-stat control strategy to realize efficient conversion from butyric acid to hexanoic acid / octanoic acid; and (4) a hydrophobic hollow fiber membrane module is adopted to realize on-line removal of the product, and the inhibition effect of the product is relieved. According to the technology, the yield of the MCFA produced from the waste molasses reaches 0.45 g / g COD, the cost is reduced by 68% compared with that of a traditional substrate, and a new way is provided for recycling of sugar manufacturing waste.
Owner:XIANGTAN UNIV

Microbial agent for efficiently producing acid by fermenting organic wastes and application of microbial agent

The invention provides a microbial agent for producing acid through fermentation of organic waste and application of the microbial agent, and relates to the technical field of biology, the microbial agent contains Acetobacter xylinum, Clostridium bovifaecis and Eubacter mucilaginosus, and the microbial agent is prepared from the following raw materials: Acetobacter xylinum, Clostridium bovifaecis and Eubacter mucilaginosus. Studies find that acetobacter burgii, clostridium cow dung and eubacterium mucilaginosus complement each other in the anaerobic fermentation process, the degradation efficiency of organic matters such as carbohydrates and proteins in the organic wastewater / perishable garbage is improved, the yield of volatile fatty acids is remarkably increased, meanwhile, the emission of CO2 is reduced, and the environmental pollution is reduced. The method has the application prospects of organic wastewater / perishable garbage treatment and recycling. When the acid-producing bacterium agent is applied to organic wastewater / perishable garbage, the fermented mixed acid liquid is rich in VFA and can be used as an organic carbon source, and the additional value is higher; when the acid-producing bacterium agent is applied to organic wastewater / perishable garbage, the operation is simple and convenient, the cost is low, biogas slurry treatment links and cost are reduced, the added value of products can be improved, and the acid-producing bacterium agent has an engineering application prospect.
Owner:WUXI UNIV

Clostridium ethanolicum as well as separation and purification method and application thereof

The invention provides clostridium ethanolicum as well as a separation and purification method and application thereof, and belongs to the field of biological fermentation. The clostridium acetobutylicum is clostridium acetobutylicum SGLT-Ca-0001-mut 1, the preservation number of the clostridium acetobutylicum SGLT-Ca-0001-mut 1 is GDMCC 63758, the preservation address of the clostridium acetobutylicum SGLT-Ca-0001-mut 1 is Guangdong Microbiological Culture Collection Center, and the preservation date of the clostridium acetobutylicum SGLT-Ca-0001-mut 1 is August 7, 2024. According to the method, plate culture is combined with first genotype identification, infectious microbes in fermentation liquor can be preliminarily screened out to preliminarily obtain relatively pure ethanol clostridium single colonies, then the ethanol clostridium single colonies in the relatively pure ethanol clostridium single colonies can be further screened out through enrichment culture and second gene identification, and in addition, the ethanol clostridium single colonies in the relatively pure ethanol clostridium single colonies can be further screened out by combining a preset culture environment. According to the method, dominant mutant clostridium ethanolicum with high production efficiency and high metabolic selectivity can be directionally screened out, and finally, the mutant clostridium ethanolicum can be screened out through multiple times of streak purification, so that clostridium ethanolicum with relatively high strain robustness and metabolic performance can be obtained.
Owner:BEIJING SHOUGANG LANZATECH TECH CO LTD

Construction method and application of a Clostridium butyricum / CdS hybrid system

The present invention discloses a method for constructing a Clostridium butyricum / CdS hybrid system and its application, which mainly comprises the following steps: (1) culturing microorganisms: culturing Clostridium butyricum at 37°C using a TGY culture medium to obtain a fresh Clostridium butyricum bacterial liquid; (2) constructing a Clostridium butyricum / CdS composite system: adding L-cysteine ​​hydrochloride and CdS to the bacterial liquid; 2+ Metal ions in situ form nanoparticles CdS and self-assemble on the surface of Clostridium butyricum cells; under light irradiation, the concentration of NADH in the Clostridium butyricum / CdS system is detected to evaluate the photocatalytic performance of the system. Starting from the current energy shortage problem, the present invention utilizes the renewable solar energy in nature to construct a photosynthetic biological hybrid system that combines the advantages of semiconductor light-harvesting ability and microbial metabolic catalytic ability, and can be applied to microorganisms to efficiently produce high value-added products such as butyric acid, H2, ethanol, 1,3-propylene glycol, etc.
Owner:HUAIYIN TEACHERS COLLEGE

Use of CD630_27900 gene in reducing tolerance to Clostridium difficile

The present invention belongs to the field of biotechnology, and specifically relates to the use of the CD630_27900 gene in reducing the tolerance of Clostridium difficile. Knocking out the CD630_27900 gene can reduce the tolerance of Clostridium difficile to acidic environments and antibiotics and reduce its cytotoxicity; the sequence of the CD630_27900 gene is shown in SEQ ID NO.1; the antibiotics include ampicillin, metronidazole, amoxicillin, vancomycin, norfloxacin, cefoxitin, clindamycin and kanamycin. The research results of the present invention suggest that the CD630_27900 gene can be used as a target for inhibiting the drug resistance and reducing the toxicity of Clostridium difficile, providing a new idea for the treatment of Clostridium difficile infection (CDI).
Owner:GUIZHOU MEDICAL UNIV